Immune drug trial offers new hope for women with early menopause to regain fertility
Disease control
Recruiting now
This study is testing whether a drug called rituximab, which calms the immune system, can help restore normal ovarian function and improve fertility in women with autoimmune premature ovarian failure (early menopause). The trial will enroll 40 women aged 18-38 who have this condi…
Phase: PHASE3 • Sponsor: Angelica Lindén Hirschberg • Aim: Disease control
Last updated Apr 06, 2026 14:06 UTC